Martin Lange
Corporate Officer/Principal bei NOVO NORDISK A/S
Aktive Positionen von Martin Lange
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01.01.2018 | - |
Pharmacosmos A/S
 Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Direktor/Vorstandsmitglied | 18.08.2023 | - |
Karriereverlauf von Martin Lange
Ehemalige bekannte Positionen von Martin Lange
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 01.01.2017 | 20.02.2020 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Direktor/Vorstandsmitglied | 01.01.2006 | 01.01.2008 |
Ausbildung von Martin Lange
| University of Copenhagen | Doctorate Degree |
Statistik
International
| Dänemark | 4 |
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
Pharmacosmos A/S
Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Health Technology |
- Börse
- Insiders
- Martin Lange
- Erfahrung
